For the study, published today in Microbial Genomics, a team of scientists at UCL Genetics Institute and Peking University People's Hospital in Beijing tracked the spread of K. pneumoniae in a Beijing hospital following a ...
Apr 2, 2019
0
1
(HealthDay)—For patients being treated for bone or joint infection, oral antibiotics are noninferior to intravenous antibiotics, according to a study published in the Jan. 31 issue of the New England Journal of Medicine.
Jan 31, 2019
0
1
(HealthDay)—For infants with uncomplicated, late-onset group B Streptococcus (GBS) bacteremia, a shortened intravenous (IV) course of antibiotic therapy is sometimes prescribed and is associated with low rates of disease ...
Oct 11, 2018
0
1
A non-pathogenic fungus can expand in the intestines of antibiotic-treated mice and enhance the severity of allergic airways disease, according to a study published September 20 in the open-access journal PLOS Pathogens by ...
Sep 20, 2018
0
22
Bacteria—especially Gram-negative strains—are becoming increasingly resistant to current antibiotic drugs, and the development of new classes of antibiotics has slowed. Faced with these challenges, investigators are studying ...
Aug 10, 2018
0
3
Antimicrobial resistance caused by "superbugs" is a major public health issue of global concern. Drug-resistant infections kill around 700,000 people worldwide each year. The figure could increase up to 10 million by 2050, ...
Apr 23, 2018
0
6
(HealthDay)—The durations of most courses of antibiotic therapy for adult outpatients with sinusitis exceed guideline recommendations, according to a research letter published online March 26 in JAMA Internal Medicine.
Mar 30, 2018
0
3
Cases of antibiotic-resistant bacteria in hospitals have increased dramatically in recent years, and the health system faces tremendous problems as a result. Alongside Staphylococcus aureus (MRSA) and Klebsiella pneumonia, ...
Mar 8, 2018
0
10
Antibiotic use is known to have a near-immediate impact on our gut microbiota and long-term use may leave us drug resistant and vulnerable to infection.
Mar 2, 2018
0
8
(HealthDay)—The antibiotic clarithromycin (brand name: Biaxin) may increase the long-term risk of heart problems and death in patients with heart disease, according to U.S. health officials.
Feb 23, 2018
0
5
